PIASxβ is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts

Journal of Cell Science

Volumn 120, Issue 15, 2007, Pages 2565-2573

  Ali, Md Moksed ^a   Yoshizawa, Tatsuya ^a   Ishibashi, Osamu ^a   Matsuda, Akio ^a   Ikegame, Mika ^a   Shimomura, Junko ^a   Mera, Hisashi ^a   Nakashima, Kazuhisa ^b   Kawashima, Hiroyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Mineralization; Osteoblast; Osterix; PIASx

Indexed keywords

MESSENGER RNA; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT X BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE; MIZ1 PROTEIN, MOUSE; NUCLEAR PROTEIN; OSTERIX PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MECHANICAL STRESS; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SUMOYLATION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CRANIAL SUTURE; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIAL SUTURES; GENE EXPRESSION REGULATION; MICE; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; OSTEOGENESIS; PROTEIN INHIBITORS OF ACTIVATED STAT; RNA, SMALL INTERFERING; STRESS, MECHANICAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 34548292581     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.005090     Document Type: Article

References (60)

1. Arron, J. R., Winslow, M. M., Polleri, A., Chang, C. P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K. et al. (2006). NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600.
2. Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E. and Takayanagi, H. (2005). Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269.
3. Burr, D. B., Robling, A. G. and Turner, C. H. (2002). Effects of biomechanical stress on bones in animals. Bone 30, 781-786.
4. Cao, Y., Zhou, Z., Crombrugghe, B., Nakashima, K., Gunn, H., Duan, X., Jia, S. F. and Kleinerman, E. S. (2005). Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma. Cancer Res. 65, 1124-1128.
5. Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P. and Shuai, K. (1997). Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805.
6. Drissi, H., Luc, Q., Shakoori, R., Chuva de Sousa Lopes, S., Choi, J. Y., Terry, A., Hu, M., Jones, S., Neil, J. C., Lian, J. B. et al. (2000). Transcriptional autoregulation of the bone related Cbfa1/Runx2 gene. J. Cell. Physiol. 184, 341-350.
7. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997). Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
8. Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M. and Del Sal, G. (1999). Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18 6462-6471.
9. Hatta, M., Yoshimura, Y., Deyama, Y., Fukamizu, A. and Suzuki, K. (2006). Molecular characterization of the zinc finger transcription factor, Osterix. Int. J. Mol. Med. 17, 425-430.
10. Hay, R.T. (2005). SUMO: A history of modification. Mol. Cell 18, 1-12.
11. Hickory, W. B. and Nanda, R. (1987). Effect of tensile force magnitude on release of cranial suture cells into S phase. Am. J. Orthod. Dentofacial Orthop. 91, 328-334.
12. Ikegame, M., Ishibashi, O., Yoshizawa, T., Shimomura, J., Komori, T., Ozawa, H. and Kawashima, H. (2001). Tensile stress induces bone morphogenetic protein 4 (BMP-4) in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture. J. Bone Miner. Res. 16, 24-32.
13. Imoto, S., Sugiyama, K., Muromoto, R., Sato, N., Yamamoto, T. and Matsuda, T. (2003). Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3. J. Biol. Chem. 278, 34253-34258.
14. Imoto, S., Sugiyama, K., Yamamoto, T. and Matsuda, T. (2004). The ring domain of PIASy is involved in the suppression of bone morphogenctic protein-signaling pathway. Biochem. Biophys. Res. Commun. 319, 275-282.
15. Itoh, S., Udagawa, N., Takahashi, N., Yoshitake, F., Narita, H., Ebisu, S. and Ishihara, K. (2006). A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 39, 505-512.
16. Johnson, E. S. (2004). Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382.
17. Johnson, E. S. and Blobel, G. (1999). Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J. Cell Biol. 147, 981-994.
18. Kang, J. S., Alliston, T., Dellston, R. and Derynck, R. (2005). Repression of Runx2 function by TGF-β through recruitment of class II historic deacetylases by Smad3. EMBO J. 24, 2543-2555.
19. KiM S., Koga, T., Isobe, M., Kern, B. E., Yokochi, T., Chin, Y. E., Karsenty, G., Taniguchi, T. and Takayanagi, H. (2003). Star1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 17, 1979-1991.
20. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K. and Takayanagi, H. (2005). NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880-885.
21. Komori, T. (2005). Regulation of skeletal development by the Runx family of transcription factors. J. Cell. Biochem. 95, 445-453.
22. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gan, Y. H., Inada, M. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 755-764.
23. Kotaja, N., Aittomaki, S., Silvennoinen, O., Palvino, J. J. and Janne, O. A. (2000). ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14, 1986-2000.
24. Lee, H., Quinn J. C., Prasanth, K. V., Swiss, V. A., Economides, K. D., Camacho, M. M., Spector, D. L. and Abate-Shen, C. (2006). PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20, 794-794.
25. Liu, B., Liao, J., Xiaoping, R., Kushner, S. A., Chung, C. D., Chang, D. D. and Shuai, K. (1998). Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95, 10626-10631.
26. Liu, B., Mink, S., Wong, K. A., Stein, N., Getman, C., Dempsey, P. W., Wu, H. and Shoal, K. (2004). PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5, 891-898.
27. Liu, C. J., Chang, E., Yu, J., Carlson, C. S., Prazak, L., Yu. X. P., Ding, B., Lengyel, P. and Di Cesare, P. E. (2005). The interferon-inducible p204 protein acts as a transcriptional co-activator of Cbfa1 and enhances osteoblast differentiation. J. Biol. Chem. 280, 2788-2796.
28. Lu, X., Gilbert, L., He, X., Rubin, J. and Nanes, M. S. (2006). Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NFΚB pathways. J. Biol. Chem. 281, 6297-6306.
29. Lun, Y., Sawadogo, M. and Perry, M. (1997). Autoactivation of Xenopus MyoD transcription and its inhibition by USF. Cell Growth Differ. 8, 275-282.
30. Meyer, U., Kruse-Losner, B. and Wiesmann, H. P. (2006). Principles of bone formation driven by biophysical forces in craniofacial surgery. Br. J. Maxillofac. Surg. 44, 289-295.
31. Moilanen, A. M., Karvonen, U., Poukka, H, Yan, W., Toppari, J., Janne, O. A. and Palvimo, J. J. (1999). A testis-specific androgen receptor co-regulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274, 3700-3704.
32. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H. et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
33. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R. and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
34. Nishio, Y., Dong, Y., Paris, M., O'Keefe, R. J., Schwarz, E. M. and Drissi, M. (2006). Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372, 62-70.
35. Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A. and Murphy, K. M. (2000). Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 27-37.
36. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-146.
37. Poukka, H., Karvonen, U., Janne, O. A. and Palvimo, J. J. (2000). Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97, 14145-14150.
38. Rhodes, S. J., Chen, R., DiMattia, G. E., Scully, K. M., Kalla, K. A., Lin, S. C., Yu, V. C. and Rosenfeld, M. G. (1993). A tissue-specific enhancerconfers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev. 7, 913-932.
39. Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P. and Hay, R. T. (1999). SUMO-1 modification activates the transcriptional response to p53. EMBO J. 18, 6455-6461.
40. Rogers, R. S., Horvath, C. M. and Matunis, M. J. (2003). SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J. Biol. Chem. 278, 30091-30097.
41. Rosas-Acosta, G., Langereis, M. A., Deyrieux, A. and Wilson, V. G. (2005). Proteins of the PIAS family enhance the sumoylation ofthe papilloma virus E1 protein. Virology 331, 190-203.
42. Sachdev, S., Bruhn, L., Sieber, H., Pichler, A, Melchior, E. and Grossched, R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088-3103.
43. Saito, Y., Yoshizawa, T., Takizawa, F., Ikegame, M., Ishibashi, O., Okuda, K., Hara, K., Ishibashi, K., Obinata, M. and Kawashima, H. (2002). A cell line with characteristics of the periodontal ligament fibroblasts is negatively regulated for mineralization and Runx2/Cbfa1/ Osf2 activity, part of which can be overcome by bone morphogenetic protein-2. J. Cell Sci. 115, 4191-4200.
44. Santti, H., Mikkonen, L., Anand, A., Hirvonen-Santti, S., Toppari, J., Panhuysen, M., Vauti, F., Perera, M., Corte, G., Wurst, W. et al. (2005). Disruption of the murine PIASx gene results in reduced testis weight. J. Mol. Endocrinol. 34, 645-654.
45. Schmidt, D. and Muller, S. (2002). Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99, 2872-2877.
46. Schmidt, D. and Muller, S. (2003). PIAS/SUMO: New partners in transcriptional regulation. Cell. Mol. Life Sci. 60, 2561-2574.
47. Seeler, J. S. and Dejean, A. (2003). Nuclear and unnuclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4, 690-699.
48. Sharrocks, D. A. (2006). PIAS proteins and transcriptional regulation - more than just SUMO E3 ligases? Genes Dev. 20, 754-758.
49. Shuai, K. and Liu, B. (2005). Regulation of gene activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5, 593-605.
50. Song, L., Bhattacharya, S., Yunus, A. A., Lima, C. D. and Schindler, C. (2006). Stat1 and SUMO modification. Blood 108, 3237-3244.
51. Takahashi, K., Thira, T., Niki, T., Seino, C, Iguchi-Ariga, S. M. M. and Ariga, H. (2001). DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J. Biol. Chem. 276, 37556-37563.
52. Tan, J. A., Hall, S. H., Katherine, G., Hamil, K. G., Grossman, G., Petrusz, P., Liao, J., Shuai, K. and French, F. S. (2000). Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor co-regulator expressed in human testis. Mol. Endocrinol. 14, 14-26.
53. Terui, Y., Saad, N., Jia, S., Mckeon, F. and Yuan, J. (2004). Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279, 28257-28265.
54. Tsai, S. F., Strauss, E. and Orkin, S. H. (1991). Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 5, 919-931.
55. Tussie-Luna, M. I., Bayarsaihan, D., Seto, E., Ruddle, F. H. and Roy, A. L. (2002a). Physical and functional interactions of historic deacetylase 3 with TFII-I family proteins and PIASxR. Proc. Natl. Acad. Sci. USA 99, 12807-12812.
56. Tussie-Luna, M. I., Michel, B., Hakre, S. and Roy, A. L. (2002b). The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxβ/Siz2 is a transcriptional cofactor for TFII-I. J. Biol. Chem. 277, 43185-43193.
57. Ungureanu, D., Vanhatupa, S., Kotaja, N., Yang, J., Aittomaki, S., Janne, O. A., Palvimo, J. J. and Silvennoinen, O. (2003). PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102, 3311-3313.
58. Wu, L., Wu, H., Ma, L., Sangiorgi, F., Wu, N., Bell, J. R., Lyons, G. E. and Maxson, R. (1997). Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65, 3-17.
59. Xiao, L., Naganawa, T., Oburgunde, E., Gronowicz, G., Ornitz, D. M., Coffin, J. D. and Hurley, M. M. (2004). Star1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J. Biol. Chem. 279, 27743-27752.
60. Yoshizawa, T., Takizawa, F., Iizawa, F., Ishibashi, O., Kawashima, H., Matsuda, A., Endo, N. and Kawashima, H. (2004). Homeobox protein Msx2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol. Cell. Biol. 24, 3460-3472.